| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Senior VP, Finance and Pao
1 company
Nemec Sarah is a Senior VP, Finance and Pao at BOLT. Recent filings cover 5 purchases and 3 sales. Those positions are worth an estimated $55K at current prices.
Our model assigns Nemec Sarah a below-average insider score of 24/100, based on 5 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -44.6%.
Nemec Sarah's largest disclosed position is in BOLT as Senior VP, Finance and Pao, worth about $55K. The recent filings there lean toward selling, a net 2,083 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | BOLT Bolt Biotherapeutics, Inc. | Senior VP, Finance and Pao | Sell | 7,842 | $3.32 | $26,072.36 | -31.5% | - | - | |
| Jun 5, 2026 | BOLT Bolt Biotherapeutics, Inc. | Senior VP, Finance and Pao | Buy | 509 | $3.88 | $1,972.88 | +36.0% | -14.6% | - | |
| Dec 5, 2025 | BOLT Bolt Biotherapeutics, Inc. | Senior VP, Finance and Pao | Buy | 125 | $4.61 | $575.88 | +9.7% | -19.6% | - | |
| Jun 6, 2025 | BOLT Bolt Biotherapeutics, Inc. | Senior VP, Finance and Pao | Buy | 125 | $5.49 | $686.50 | +15.3% | -25.1% | -29.4% | |
| Dec 16, 2024 | BOLT Bolt Biotherapeutics, Inc. | Senior VP, Finance and Pao | Buy | 5,000 | $0.57 | $2,834.75 | +56.4% | -20.8% | -47.4% |